| Literature DB >> 22170941 |
Se-Hwan Joo1, Tae-Wuk Kim, Seung-Hyun Son, Woo Sung Lee, Takao Yokota, Seong-Ki Kim.
Abstract
A metabolic study revealed that 28-norcastasterone in Arabidopsis is synthesized from cholesterol via the late C-6 oxidation pathway. On the other hand, the early C-6 oxidation pathway was found to be interrupted because cholestanol is converted to 6-oxocholestanol, but further metabolism to 28-norcathasterone was not observed. The 6-oxoBRs were found to have been produced from the respective 6-deoxoBRs administered to the enzyme solution, thus indicating that these 6-oxoBRs are supplied from the late C-6 oxidation pathway. Heterologously expressed CYP85A1 and CYP85A2 in yeast catalysed this C-6 oxidation, with CYP85A2 being much more efficient than CYP85A1. Abnormal growth of det2 and dwf4 was restored via the application of 28-norcastasterone and closer precursors. Furthermore, det2 and dwf4 could not convert cholesterol to cholestanol and cholestanol to 6-deoxo-28-norcathasterone, respectively. It is, therefore, most likely that the same enzyme system is operant in the synthesis of both 28-norcastasterone and castasterone. In the presence of S-adenosyl-L-methionine, the cell-free enzyme extract catalysed the C-24 methylation of 28-norcastasterone to castasterone, although the conversion rates of 28-norteasterone to teasterone and 28-nortyphasterol to typhasterol were much lower; this suggests that 28-norcastasterone is the primary precursor for the generation of C(28)-BRs from C(27)-BRs.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22170941 PMCID: PMC3295382 DOI: 10.1093/jxb/err354
Source DB: PubMed Journal: J Exp Bot ISSN: 0022-0957 Impact factor: 6.992
Fig. 1.Biosynthetic pathways for C27- and C28-BRs and their connection established in A. thaliana. The solid and dashed arrows indicate verified and not verified biosynthetic steps, respectively. The names on arrows indicate genes or enzymes catalysing biosynthetic reactions. (This figure is available in colour at JXB online.)
Content of major 4-demethylasterols in A. thaliana
| Amount (μg g−1 fresh weight) | ||
| 1st experiment | 2nd experiment | |
| Cholesterol | 6.60 | 7.94 |
| Cholestanol | 0.38 | 1.45 |
| Campesterol | 22.41 | 21.06 |
| Campestanol | 1.21 | 1.02 |
| Stigmasterol | 3.62 | 4.84 |
| Sitosterol | 107.13 | 99.45 |
| Sitostanol | 8.35 | 9.68 |
GC-MS data of metabolites obtained from A. thaliana cell-free conversion experiments
| Substrate | Metabolite | RRt | Prominent Ions |
| CHR | CHN | 0.456 | 460(M+, 54), 445(73), 370(28), 355(43), 305(33), 215(100) |
| CHN | 6-oxoCHN | 0.495 | 474 (M+, 19), 459(51), 445(100), 384(4), 159(8) |
| 6-deoxo-28-norCT | 0.542 | 533(M+-15, 1), 368(2), 255(8), 173(100) | |
| 6-deoxo-28-norTE | 0.605 | 516(M+, 69), 501(55), 459(23), 426(26), 411(39), 305(35), 230(27), 215(100), 141(30) | |
| 28-norTE | 28-nor-3-DHT | 0.876 | 456(M+, 90), 399(3), 316(19), 286(13), 245(35), 141(100) |
| 28-norTY | 0.735 | 530(M+, 60), 515(35), 501(100), 440(56), 425(21), 229(16), 141(21) | |
| TE | 1.031 | 544(M+, 29), 529(53), 515(100), 454(5), 300(8), 155(39) | |
| 28-nor-3-DHT | 3-DHT | 1.013 | 470(M+, 63), 399(7), 357(5), 316(21), 298(10), 287(11), 245(11), 155(100) |
| 28-norTY | 28-nor-3-DHT | 0.876 | 456(M+, 90), 399(2), 316(16), 286(11), 245(36), 141(100) |
| 28-norTE | 0.906 | 530(M+, 21), 515(53), 501(100), 440(3), 316(16), 141(11) | |
| 28-norCS | 0.866 | 498(M+, 100), 483(8), 399(4), 358(12), 328(7), 287(36), 141(52) | |
| TY | 0.863 | 544(M+, 100), 529(81), 515(55), 454(72), 300(10), 155(60) | |
| 28-norCS | CS | 1.000 | 512(M+, 80), 358(33), 327(12), 287(32), 155(100) |
| 6-deoxo-28-norTE | 6-deoxo-28-nor-3-DHT | 0.615 | 442(M+, 73), 427(10), 246(12), 231(100), 217(23), 163(20), 141(15) |
| 6-deoxo-28-norTY | 0.523 | 516(M+, 23), 501(6), 459(4), 426(62), 411(60), 305(11), 230(30), 215(100), 141(24) | |
| 28-norTE | 0.906 | 530(M+, 21), 515(50), 501(100), 440(5), 316(18), 141(12) | |
| 6-deoxo-28-nor-3-DHT | 6-deoxo-28-norTE | 0.605 | 516(M+, 73), 501(65), 459(25), 426(23), 411(36), 305(38), 230(26), 215(100), 141(17) |
| 6-deoxo-28-norTY | 0.523 | 516(M+, 21), 501(5), 459(4), 426(60), 411(59), 305(10), 230(32), 215(100), 141(24) | |
| 28-nor-3-DHT | 0.876 | 456(M+, 91), 399(3), 316(20), 286(13), 245(33), 141(100) | |
| 6-deoxo-28-norTY | 6-deoxo-28-nor-3-DHT | 0.615 | 442(M+, 74), 427(10), 246(12), 231(100), 217(22), 163(20), 141(14) |
| 6-deoxo-28-norTE | 0.605 | 516(M+, 71), 501(62), 459(25), 426(23), 411(35), 305(36), 230(26), 215(100), 141(23) | |
| 28-norTY | 0.735 | 530(M+, 60), 515(34), 501(100), 440(55), 425(24), 229(15), 141(23) | |
| 6-deoxo-28-norCS | 0.619 | 484(M+, 51), 469(16), 288(15), 273(100), 205(24), 141(21) | |
| 6-deoxo-28-norCS | 28-norCS | 0.866 | 498(M+, 100), 483(3), 399(4), 358(12), 328(7), 287(36), 141(54) |
RRt: relative retention time on GC.
The sample was analysed as BMB.
The sample was analysed as BMB-TMSi ether.
Fig. 2.Comparison of BR C-6 oxidase activity in CYP85A1/V60/WAT21 and CYP85A2/V60/WAT21 strains. (A) C-6 oxidation for C27-BRs, (B) C-6 oxidation for C28-BRs.
Fig. 3.Metabolism of 28-norCS in Arabidopsis. 28-NorCS converted to 26,28-didemethyl-CS (tentative), but not to 28-norBL.
GC-MS/SIM data for C24-methylation of 28-norTE, 28-nor-3-DHT, 28-norTY, 28-norCS to TE, 3-DHT, TY, and CS in the presence of SAM and NADPH
| Substrate | Metabolite | Conversion rate (%) |
| 28-norTE | TE | 0.2 |
| 28-nor-3-DHT | 3-DHT | 0.2 |
| 28-norTY | TY | 0.3 |
| 28-norCS | CS | 6.0 |
Fig. 4.Growth recovery of det2 (A) and dwf4 (B) by C27-sterols and C27-BRs. (A) A, Col-0/B-L, det2; B, Control; C, det2+cholesterol; D, det2+Cholest-4-en-3-one; E, det2+cholestanol; F, det2+6-deoxo-28-norCT; G, det2+6-deoxo-28-norTE; H, det2+6-deoxo-28-norTY; I, det2+6-oxocholestanol; J, det2+28-norTE; K, det2+28-norTY; L, det2+28-norCS. (B) a, Wild-type (En-2); b, dwf4; c, dwf4+6-oxocholestanol; d, dwf4+28-norTE; e, dwf4+28-norTY; f, dwf4+28-norCS. Error bars donate standard errors (n >30).
Fig. 5.GC-SIM analysis conversion of cholesterol to cholestanol and cholestanol to 6-deoxo-28-norCT in det2 (B) and dwf4 (D), respectively. (A) Conversion of cholesterol to cholestanol in Col-0, the wild type of det2. (C) Conversion of cholestanol to 6-deoxo-28-norCT in En-2, the wild type of dwf4.
Fig. 6.A proposed scheme for the three step C-24 methylation of 28-norCS to CS in the presence of SAM and NADPH in Arabidopsis. S indicates the same ring structure as that of 28-norCS and CS.
Fig. 7.Biosynthetic connection of C27-BRs (28-norBRs), C28-BRs (24-methylene BRs and 24-methyl BRs) and C29-BRs (24-ethyl BRs) in plants. The multiple BRs biosynthetic pathways are funneled into CS to show BR activity in plant growth and development.